Chinese General Practice ›› 2022, Vol. 25 ›› Issue (36): 4595-4600.DOI: 10.12114/j.issn.1007-9572.2022.0330
• Review • Previous Articles Next Articles
Received:
2022-05-22
Revised:
2022-06-25
Published:
2022-12-20
Online:
2022-09-22
Contact:
ZHANG Anren
About author:
通讯作者:
张安仁
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0330
研究者 | 受试样本 | 丰度降低的肠道菌群 | 丰度增加的肠道菌群 |
---|---|---|---|
KIM等[ | 16例UC患者和15例健康者 | Bacteroidetes | Fusobacteria、Proteobacteria |
LEHMANN等[ | 14例UC患者和17例健康者 | Phyla Bacteroidetes、Spirochaetes、Tenericutes | — |
FACCHIN等[ | 30例UC患者和18例健康者 | Lachnospiraceae、Ruminoclostridium | Clostridium |
IMAI等[ | 20例CD患者和20例健康者 | phyla Firmicutes、Bacteroidetes、Faecalibacterium | Enterococcus |
LEHMANN等[ | 11例CD患者和17例健康者 | Acidobacteria | — |
FACCHIN等[ | 19例CD患者和18例健康者 | Feacalibacterium、Akkermansia、Lachnospiraceae | Anaerotruncus、Oscillospira |
Table 1 Characteristics of intestinal flora in patients with inflammatory bowel disease
研究者 | 受试样本 | 丰度降低的肠道菌群 | 丰度增加的肠道菌群 |
---|---|---|---|
KIM等[ | 16例UC患者和15例健康者 | Bacteroidetes | Fusobacteria、Proteobacteria |
LEHMANN等[ | 14例UC患者和17例健康者 | Phyla Bacteroidetes、Spirochaetes、Tenericutes | — |
FACCHIN等[ | 30例UC患者和18例健康者 | Lachnospiraceae、Ruminoclostridium | Clostridium |
IMAI等[ | 20例CD患者和20例健康者 | phyla Firmicutes、Bacteroidetes、Faecalibacterium | Enterococcus |
LEHMANN等[ | 11例CD患者和17例健康者 | Acidobacteria | — |
FACCHIN等[ | 19例CD患者和18例健康者 | Feacalibacterium、Akkermansia、Lachnospiraceae | Anaerotruncus、Oscillospira |
[1] |
|
[2] | |
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
唐昱婷,汤加勇,赵华. 鼠李糖乳杆菌对肠道屏障功能的影响机制研究进展[J]. 四川农业大学学报,2021,39(4):427-432. DOI:10.16036/j.issn.1000-2650.2021.04.002.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[1] | XIAO Liqi, YANG Li, CUI Saixian, ZHANG Yayuan, WANG Yulu, HE Yan. Advances in the Association of High Salt-induced Gut Microbiota Disturbances with Salt-sensitive Blood Pressure [J]. Chinese General Practice, 2023, 26(29): 3704-3709. |
[2] | PU Yu, ZHANG Jixiang, DONG Weiguo. Advances in Ferroptosis and Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(29): 3698-3703. |
[3] | ZHANG Zhendong, CAI Bin, WANG Hongwei, QIAO Zengyong. Study on the Changes of Intestinal Flora and Its Metabolite Phenylacetylglutamine in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2023, 26(29): 3665-3673. |
[4] | CHEN Xiaofen, CHEN Yuhan, MA Juan. Recent Strides in Novel Treatments for Inflammatory Bowel Disease [J]. Chinese General Practice, 2023, 26(27): 3349-3354. |
[5] | QIN Yuning, ZHAO Tianyi, LIU Fengbin, WANG Xin, CAO Xue, SUN Minglin, LAI Keyun, DI Luyao, GE Zhishan, LIU Song, XING Ying, YANG Lei, YUE Lihong, ZOU Meimei, HE Liyun, LI Hongjiao. Research of the Measurement Properties of the Chinese Version of the Gastrointestinal Symptom Rating Scale for Patients with Gastrointestinal Diseases [J]. Chinese General Practice, 2023, 26(18): 2277-2285. |
[6] | FU Weiqiang, ZHOU Jianbo, WU Xiongjian, HUANG Caibin. Treatment Strategy of Nonalcoholic Fatty Liver Disease Targeting the Intestinal Microbiota [J]. Chinese General Practice, 2023, 26(06): 742-748. |
[7] | SHAO Wei, HUANG Mengmeng, HE Dandan, HUANG Fuxin, NIU Hongyue. Influencing Factors of Severity of Functional Dyspepsia after Ischemic Stroke [J]. Chinese General Practice, 2022, 25(36): 4509-4514. |
[8] | Jianfeng LUO, Jiangtao HOU, Zhengkun HOU, Bin PENG, Huibiao LI, Shiying LIU, Zhenfan HE, Jiamin ZHONG, Shijing ZHANG, Fengbin LIU, Xinlin CHEN. Development and Item Selection of the Inflammatory Bowel Disease Patient-reported Outcomes Scale Based on Theories of Traditional Chinese Medicine [J]. Chinese General Practice, 2022, 25(29): 3672-3677. |
[9] | Lei MO, Ping ZHONG. Study on the Relationship between Intestinal Microflora Differences and the Incidence of Preeclampsia in Pregnant Women in the Early and Middle Stages of Pregnancy [J]. Chinese General Practice, 2022, 25(20): 2489-2492. |
[10] | Xue XIAO, Yuqi WANG, Xiaolan LAI, Shaotao ZHONG, Cuiliu ZHAO, Dan LIU, Lin LI, Rongshao TAN, Hongling YANG. Effect of Maternal Intestinal Floras on Neonatal Birth Weight [J]. Chinese General Practice, 2022, 25(19): 2363-2370. |
[11] | Xiaojun HUANG, Jin YANG, Yaqimei LEI, Zhijie ZENG, Zhaohui JIN. New Research Progress of a New Auxiliary Antihypertensive Model Targeting Intestinal Flora [J]. Chinese General Practice, 2022, 25(18): 2297-2302. |
[12] | Qiuyu CEN, Rizhao PANG, Xiaomin HU, Yanru CUI, Anren ZHANG. New Developments in the Role of Lactobacillus Reuteri in Regulating Intestinal Barrier Function [J]. Chinese General Practice, 2022, 25(15): 1918-1922. |
[13] | Hongyu HUANG, Tiantian LEI, Hongsheng MA, Renwei HU, Jinlin YANG. Pyoderma Gangrenosum with Crohn's Disease Presenting as a Giant Foot Ulcer: a Case Report and Literature Review [J]. Chinese General Practice, 2022, 25(15): 1906-1909. |
[14] | Zhanpeng LIU, Xiaozhong YANG, Mengxue CHEN, Menghui ZHANG, Honggang WANG. Clinical Value of Inflammatory Bowel Disease Symptom Inventory in Evaluating the Activity of Inflammatory Bowel Disease [J]. Chinese General Practice, 2022, 25(14): 1713-1718. |
[15] |
ZENG Lin, ZHANG Pengxiang, HUANG Qian, WANG Gaoxiang, LI Huilin.
Research Progress of the Prevention and Treatment of Metabolic Diseases Based on Short Chain Fatty Acids [J]. Chinese General Practice, 2022, 25(09): 1141-1147. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||